❌

Normal view

Train clinical AI to reason like a team of doctors

Nature, Published online: 04 March 2025; doi:10.1038/d41586-025-00618-x

As the European Union’s Artificial Intelligence Act takes effect, AI systems that mimic how human teams collaborate can improve trust in high-risk situations, such as clinical medicine.

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells

STAR Protoc. 2025 Feb 11;6(1):103635. doi: 10.1016/j.xpro.2025.103635. Online ahead of print.

ABSTRACT

We introduce a protocol for generating 3D organoids from circulating tumor cells (CTCs), enabling longitudinal functional and molecular analyses in pancreatic cancer patients, including those with unresectable disease, which constitutes the majority of cases. We outline the process for isolating and characterizing CTCs from the blood of pancreatic cancer patients and provide detailed instructions for initiating, passaging, and phenotyping CTC-derived organoids. Additionally, we describe techniques for utilizing these organoids in drug screening with a focus on stemness-related pathways. For complete details on the use and execution of this protocol, please refer to Tang et al.1.

PMID:39946239 | PMC:PMC11870243 | DOI:10.1016/j.xpro.2025.103635

Presentation: Modernizing DevOps with AI, Boosting Productivity, and Redefining Developer Experience

The panelists discuss how generative AI is boosting productivity, redefining the developer experience, and affecting software development in 2025.

By Christian Bonzelet, Jessica Andersson, Garima Bajpai, Shobhit Verma, Renato Losio

A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor

Characterization of a common germline variant in PCSK9 unveils a hereditary basis underlying breast cancer metastasis and suggests that PCSK9 inhibition therapy could be a promising strategy for breast cancer metastasis prevention.

Heritable polygenic editing: the next frontier in genomic medicine?

Nature, Published online: 08 January 2025; doi:10.1038/s41586-024-08300-4

We discuss the potential consequences and ethical concerns of polygenic genome editing of human embryos to alter specific variants associated with polygenic diseases, highlighting the possibility of reducing disease susceptibility while exacerbating health inequalities.

Complex rearrangements fuel ER<sup>+</sup> and HER2<sup>+</sup> breast tumours

Nature, Published online: 08 January 2025; doi:10.1038/s41586-024-08377-x

A study identifies three dominant genomic archetypes of breast cancer induced by discrete mutational processes, describing a continuum of genomic profiles and detailing the mechanisms underlying the progression of breast cancer.

High-resolution genomic history of early medieval Europe

Nature, Published online: 01 January 2025; doi:10.1038/s41586-024-08275-2

Twigstats, a method for ancestry reconstruction, provides high-resolution genetic histories and movement patterns of people living in Europe during the first millennium ce.

How to build the virtual cell with artificial intelligence: Priorities and opportunities

Advances in AI and omics enable the creation of AI virtual cells (AIVCs)—multi-scale, multimodal neural network models that simulate molecules, cells, and tissues across diverse states. This vision outlines their design and collaborative development, promising to transform biological research through high-fidelity simulations, accelerating discoveries, and fostering interdisciplinary open science collaborations.

Evolutionary trajectories of small cell lung cancer under therapy

Nature, Published online: 13 March 2024; doi:10.1038/s41586-024-07177-7

We uncover key processes of the genomic evolution of small cell lung cancer under therapy, identify the common ancestor as the source of clonal diversity at relapse and show central genomic patterns associated with drug response.

Genome-wide characterization of circulating metabolic biomarkers

Nature, Published online: 06 March 2024; doi:10.1038/s41586-024-07148-y

A meta-analysis of genome-wide association studies for 233 circulating metabolites from 33 cohorts reveals more than 400 loci and suggests probable causal genes, providing insights into metabolic pathways and disease aetiology.

Pan-cancer proteogenomics characterization of tumor immunity

Immunotherapy holds strong promise for cancer treatment but at present benefits only a small proportion of cases. A pan-cancer analysis of the immune landscape in more than 1,000 tumors across ten cancer types reveals immune surveillance and immune evasion mechanisms as well as potential molecular target that could augment future immunotherapy and precision medicine strategies.
❌